我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
12
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1992
进行中（未招募）
1
8.3%
已完成
6
50.0%
尚未招募
招募中
Unknown
3
25.0%
暂无批准数据
- Researchers from the University of Derby and Plymouth have initiated the UK's first anti-viral drug trial for long COVID, testing medication previously used only for hospitalized COVID-19 patients. - The £1.25m ERASE project involves 72 participants receiving intravenous anti-viral treatment over five days, aiming to address symptoms like fatigue, breathlessness, and brain fog affecting over 2 million UK residents. - Early participant Ryan Cawley reports significant improvement in symptoms after receiving the treatment, describing feeling "like I have been given a new pair of lungs" and experiencing an "upward trajectory to recovery."
